On Mar. 9, 2023, the U.S. Food and Drug Administration (FDA) announced that it had published updates to…
On Feb. 3, 2023, the World Health Organization (WHO) released an updated Global Breast Cancer Initiative (GBCI) Framework…
On Nov. 16, 2022, the Cancer Prevention and Research Institute of Texas (CPRIT) approved $12 million in recruitment…
On Sept. 27, 2022, the National Institutes of Health (NIH) announced that a large international study had confirmed…
On Aug. 5, 2022, the U.S. Food and Drug Administration (FDA) approved Daiichi Sankyo’s Enhertu (fam-trastuzumab-deruxtecan-nxki), an IV…
On Jun. 21, 2022, Anixa Biosciences announced the publication of a peer-reviewed journal article in Clinical and Experimental…
On Apr. 6, 2022, a new study in the Journal of Clinical Oncology showed that women receiving certain…
On Apr. 1, 2022, the Fred Hutchinson Cancer Research Center and Seattle Cancer Care Alliance (SCCA) announced a…
On Feb. 17, 2022, after studying blood samples from 244 patients hospitalized for COVID-19, a group of researchers,…
On Feb. 8, 2022, a research team led at Boston University School of Public Health reported on links…
On Oct. 26, 2021, Anixa Biosciences announced that, in conjunction with its partner, Cleveland Clinic, it had commenced…
On Mar. 16, 2021, research from the World Health Organization (WHO) and partners showed that the COVID-19 pandemic…
On Mar. 16, 2021, Moderna announced that the first participants had been dosed in the Phase 2/3 study,…
On Jan. 28, 2021, National Institutes of Health (NIH) researchers reported that pregnant women who experienced severe symptoms…
On Jan. 25, 2021, the National Institutes of Health (NIH) announced that in large clinical trial conducted worldwide,…
On Jan. 12, 2021, the Tufts Center for the Study of Drug Development (Tufts CSDD) reported that ever…
On Nov. 4, 2020, McGill University Professor William Foulkes awarded 2020 Wilder-Penfield Prize for research in the genetics…
On Aug. 13, 2020, in a first-of-its-kind study in humans, investigators at the Center for ADHD Research at…
On Apr. 6, 2020, the National Cancer Institute awarded of $14.54 million to Roswell Park Comprehensive Cancer Center…
On Mar. 11, 2020, the antiretroviral drugs dolutegravir and emtricitabine/tenofovir alafenamide fumarate (DTG+FTC/TAF) may comprise the safest and…
On Mar. 9, 2020, among African adolescent girls and young women who took HIV pre-exposure prophylaxis (PrEP) daily,…
On Feb. 17, 2020, the University of Gothenburg announced that the team responsible for uterine transplantation research has,…
On Jan. 29, 2020, Sorrento Therapeutics announced it had initiated a clinical and manufacturing collaboration with Celularity, a…
On Jan. 9, 2020, Penn Medicine announced the birth of Benjamin Thomas Gobrecht: his mother, 33-year-old Jennifer Gobrecht,…
On Dec. 23, 2019, the Barbara Ann Karmanos Cancer Institute received the 2020 Women’s Choice Award as one…
On Dec. 20, 2019, the U.S. Food and Drug Administration (FDA) granted accelerated approval to Daiichi Sankyo’s Enhertu…
On Jan. 18, 2019, Masonic Cancer Center researchers received $1.4 million in grants for ovarian cancer research from…
On Aug. 24, 2018, the Cancer Prevention and Research Institute of Texas (CPRIT) announced it passed a $2…
On Jul. 18, 2018, the Nuffield Council on Bioethics said that changing the DNA of a human embryo…
On Mar. 9, 2018, Seattle Genetics announced it had completed its acquisition of Cascadian Therapeutics for approximately $614…